Medical Imaging Reagents Market: Global Industry Analysis and Forecast (2023-2029)

Medical Imaging Reagents Market was valued US$ 14.17 Bn in 2022 and is expected to reach 24.95 Bn by 2029, at a CAGR of 8.42 % during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.Medical Imaging Reagents MarketTo know about the Research Methodology:-Request Free Sample Report Medical imaging reagents are chemicals, which are used to picture structures or organs and assist physicians to better analyze and detect diseases. The global medical imaging reagents market is driven by factors like increasing cases of chronic diseases like cancer and cardiovascular diseases, the surge in technological advancements, and high unmet medical and diagnostic imaging process needs. Additionally, rising geriatric population, upsurge in expenditure on healthcare and increasing demand for effective procedures and safe medication are expected to boom the global medical imaging reagents market. Furthermore, the lack of reagent suppliers and stringent government regulations in developing regions are limiting the growth in the global medical imaging reagents market. Contrast reagents are widely used in the healthcare industry to enhance the clarity of the images of the tissues, organs, and physiologic processes, which can be produced by modalities like X-ray, CT, MRI, and ultrasound. The growing incidence of CVD and cancer and increasing investments in research and developmental activities will lift the adoption of contrast reagents or contrast media or contrast materials. Increasing inclination towards the adoption of personalized diagnostic procedures is expected to boost the global medical imaging reagents market growth by contrast reagents segment. Diagnostic imaging refers to the usage of technologies, which help to diagnose numerous pathologies by visualizing different components inside the body. It is gradually becoming an important part of the diagnostic cases for healthcare professionals owing to the unparalleled results, which the imaging techniques can provide into the human body. Many imaging technologies like MRI, CT, and PET are becoming part of the daily routine procedures performed in hospitals, worldwide. Imaging reagents assistance healthcare practitioners to envisage abnormalities on a diagnostic image. Geographically, North America is expected to dominate the global medical imaging reagents market. The dominated position in the market can be attributed to the increasing adoption of several types of modalities by end users. The technological advancements, the occurrence of chronic diseases like cancer, cardiovascular disease, and others are also expected to increase demand for medical imaging reagents. Furthermore, Europe is the second largest market for medical imaging reagents owing to rising health awareness among people and a growing number of research and development activities. On the other hand, Asia-Pacific is expected to grow at a xx% rate of CAGR during the forecast period owing to growth in population, an upsurge in opportunity for clinical and preclinical studies at low costs, and government support for research and development activities. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding dynamics, structure by analysing the market segments and, project the global medical imaging reagents market. The report also provides a clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global medical imaging reagents market. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders in arranging the efforts and investment in the near future to a particular market segment.

Medical Imaging Reagents Market Scope: Inquire before buying

Medical Imaging Reagents Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2017 to 2022 Market Size in 2022: US $ 14.17 Bn.
Forecast Period 2023 to 2029 CAGR: 8.42% Market Size in 2029: US $ 24.95 Bn.
Segments Covered: by Class • Contrast Reagents • Optical Reagents • Nuclear Reagents
by Technology • Nanoparticles • Fluorescent Dyes & Probes • Radiopharmaceuticals • Fluorescent Proteins • Quantum Dots
by Application • Diagnostics • Drug Discovery & Development • R&D

Medical Imaging Reagents Market, by Region

North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)

 Medical Imaging Reagents Market Key players

• Bayer Healthcare AG • Becton Dickinson & Company • Bracco Imaging SpA • Cardinal Health, Inc. • GE Healthcare • Lantheus Medical Imaging, Inc. • Mallinckrodt Pharmaceuticals • Thermo Fisher Scientific, Inc. • Promega Corporation • Danaher Corporation • Siemens Healthcare • Merck & Co., Inc. • Shimadzu Corporation • Koninklijke Philips N.V. • Covalon Technologies Ltd., • Guerbet Group • Isologic Innovative Radiopharmaceuticals • Piramal Imaging • SHINE Medical Technologies Frequently Asked Questions: 1. Which region has the largest share in Global Medical Imaging Reagents Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Medical Imaging Reagents Market? Ans: The Global Medical Imaging Reagents Market is growing at a CAGR of 8.42% during forecasting period 2023-2029. 3. What is scope of the Global Medical Imaging Reagents Market report? Ans: Global Medical Imaging Reagents Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Medical Imaging Reagents Market? Ans: The important key players in the Global Medical Imaging Reagents Market are – Bayer Healthcare AG, Becton Dickinson & Company, Bracco Imaging SpA, Cardinal Health, Inc., GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals, Thermo Fisher Scientific, Inc., Promega Corporation, Danaher Corporation, Siemens Healthcare, Merck & Co., Inc., Shimadzu Corporation, Koninklijke Philips N.V., Covalon Technologies Ltd.,, Guerbet Group, Isologic Innovative Radiopharmaceuticals, Piramal Imaging, SHINE Medical Technologies 5. What is the study period of this Market? Ans: The Global Medical Imaging Reagents Market is studied from 2022 to 2029.

Global Medical Imaging Reagents Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Medical Imaging Reagents Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Global Medical Imaging Reagents Market Industry Trends 4.8.Global Medical Imaging Reagents Market Competitive Landscape 5. Supply Side and Demand Side Indicators 6. Global Medical Imaging Reagents Market Analysis and Forecast 6.1. Global Medical Imaging Reagents Market Size & Y-o-Y Growth Analysis 1wq`0-0A 7. Global Medical Imaging Reagents Market Analysis and Forecast, by Class 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Medical Imaging Reagents Market Value Share Analysis, by Class 7.4. Global Medical Imaging Reagents Market Size (US$ Bn) Forecast, by Class 7.5. Global Medical Imaging Reagents Market Analysis, by Class 7.6. Global Medical Imaging Reagents Market Attractiveness Analysis, by Class 8. Global Medical Imaging Reagents Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Medical Imaging Reagents Market Value Share Analysis, by Application 8.4. Global Medical Imaging Reagents Market Size (US$ Bn) Forecast, by Application 8.5. Global Medical Imaging Reagents Market Analysis, by Application 8.6. Global Medical Imaging Reagents Market Attractiveness Analysis, by Application 9. Global Medical Imaging Reagents Market Analysis and Forecast, by Technology 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Medical Imaging Reagents Market Value Share Analysis, by Technology 9.4. Global Medical Imaging Reagents Market Size (US$ Bn) Forecast, by Technology 9.5. Global Medical Imaging Reagents Market Analysis, by Technology 9.6. Global Medical Imaging Reagents Market Attractiveness Analysis, by Technology 10. Global Medical Imaging Reagents Market Analysis, by Region 10.1. Global Medical Imaging Reagents Market Value Share Analysis, by Region 10.2. Global Medical Imaging Reagents Market Size (US$ Bn) Forecast, by Region 10.3. Global Medical Imaging Reagents Market Attractiveness Analysis, by Region 11. North America Medical Imaging Reagents Market Analysis 11.1. Key Findings 11.2. North America Medical Imaging Reagents Market Overview 11.3. North America Medical Imaging Reagents Market Value Share Analysis, by Class 11.4. North America Medical Imaging Reagents Market Forecast, by Class 11.4.1. Contrast Reagents 11.4.2. Optical Reagents 11.4.3. Nuclear Reagents 11.5. North America Medical Imaging Reagents Market Value Share Analysis, by Application 11.6. North America Medical Imaging Reagents Market Forecast, by Application 11.6.1. Diagnostics 11.6.2. Drug Discovery & Development 11.6.3. R&D 11.6.4. Others 11.7. North America Medical Imaging Reagents Market Value Share Analysis, by Technology 11.8. North America Medical Imaging Reagents Market Forecast, by Technology 11.8.1. Nanoparticles 11.8.2. Fluorescent Dyes & Probes 11.8.3. Radiopharmaceuticals 11.8.4. Fluorescent Proteins 11.8.5. Quantum Dots 11.9. North America Medical Imaging Reagents Market Value Share Analysis, by Country 11.10. North America Medical Imaging Reagents Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Medical Imaging Reagents Market Analysis, by Country 11.12. U.S. Medical Imaging Reagents Market Forecast, by Class 11.12.1. Contrast Reagents 11.12.2. Optical Reagents 11.12.3. Nuclear Reagents 11.13. U.S. Medical Imaging Reagents Market Forecast, by Application 11.13.1. Diagnostics 11.13.2. Drug Discovery & Development 11.13.3. R&D 11.13.4. Others 11.14. U.S. Medical Imaging Reagents Market Forecast, by Technology 11.14.1. Nanoparticles 11.14.2. Fluorescent Dyes & Probes 11.14.3. Radiopharmaceuticals 11.14.4. Fluorescent Proteins 11.14.5. Quantum Dots 11.15. Canada Medical Imaging Reagents Market Forecast, by Class 11.15.1. Contrast Reagents 11.15.2. Optical Reagents 11.15.3. Nuclear Reagents 11.16. Canada Medical Imaging Reagents Market Forecast, by Application 11.16.1. Diagnostics 11.16.2. Drug Discovery & Development 11.16.3. R&D 11.16.4. Others 11.17. Canada Medical Imaging Reagents Market Forecast, by Technology 11.17.1. Nanoparticles 11.17.2. Fluorescent Dyes & Probes 11.17.3. Radiopharmaceuticals 11.17.4. Fluorescent Proteins 11.17.5. Quantum Dots 11.18. North America Medical Imaging Reagents Market Attractiveness Analysis 11.18.1. By Class 11.18.2. By Application 11.18.3. By Technology 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Medical Imaging Reagents Market Analysis 12.1. Key Findings 12.2. Europe Medical Imaging Reagents Market Overview 12.3. Europe Medical Imaging Reagents Market Value Share Analysis, by Class 12.4. Europe Medical Imaging Reagents Market Forecast, by Class 12.4.1. Contrast Reagents 12.4.2. Optical Reagents 12.4.3. Nuclear Reagents 12.5. Europe Medical Imaging Reagents Market Value Share Analysis, by Application 12.6. Europe Medical Imaging Reagents Market Forecast, by Application 12.6.1. Diagnostics 12.6.2. Drug Discovery & Development 12.6.3. R&D 12.6.4. Others 12.7. Europe Medical Imaging Reagents Market Value Share Analysis, by Technology 12.8. Europe Medical Imaging Reagents Market Forecast, by Technology 12.8.1. Nanoparticles 12.8.2. Fluorescent Dyes & Probes 12.8.3. Radiopharmaceuticals 12.8.4. Fluorescent Proteins 12.8.5. Quantum Dots 12.9. Europe Medical Imaging Reagents Market Value Share Analysis, by Country 12.10. Europe Medical Imaging Reagents Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Medical Imaging Reagents Market Analysis, by Country 12.12. Germany Medical Imaging Reagents Market Forecast, by Class 12.12.1. Contrast Reagents 12.12.2. Optical Reagents 12.12.3. Nuclear Reagents 12.13. Germany Medical Imaging Reagents Market Forecast, by Application 12.13.1. Diagnostics 12.13.2. Drug Discovery & Development 12.13.3. R&D 12.13.4. Others 12.14. Germany Medical Imaging Reagents Market Forecast, by Technology 12.14.1. Nanoparticles 12.14.2. Fluorescent Dyes & Probes 12.14.3. Radiopharmaceuticals 12.14.4. Fluorescent Proteins 12.14.5. Quantum Dots 12.15. U.K. Medical Imaging Reagents Market Forecast, by Class 12.15.1. Contrast Reagents 12.15.2. Optical Reagents 12.15.3. Nuclear Reagents 12.16. U.K. Medical Imaging Reagents Market Forecast, by Application 12.16.1. Diagnostics 12.16.2. Drug Discovery & Development 12.16.3. R&D 12.16.4. Others 12.17. U.K. Medical Imaging Reagents Market Forecast, by Technology 12.17.1. Nanoparticles 12.17.2. Fluorescent Dyes & Probes 12.17.3. Radiopharmaceuticals 12.17.4. Fluorescent Proteins 12.17.5. Quantum Dots 12.18. France Medical Imaging Reagents Market Forecast, by Class 12.18.1. Contrast Reagents 12.18.2. Optical Reagents 12.18.3. Nuclear Reagents 12.19. France Medical Imaging Reagents Market Forecast, by Application 12.19.1. Diagnostics 12.19.2. Drug Discovery & Development 12.19.3. R&D 12.20. France Medical Imaging Reagents Market Forecast, by Technology 12.20.1. Nanoparticles 12.20.2. Fluorescent Dyes & Probes 12.20.3. Radiopharmaceuticals 12.20.4. Fluorescent Proteins 12.20.5. Quantum Dots 12.21. Italy Medical Imaging Reagents Market Forecast, by Class 12.21.1. Contrast Reagents 12.21.2. Optical Reagents 12.21.3. Nuclear Reagents 12.22. Italy Medical Imaging Reagents Market Forecast, by Application 12.22.1. Diagnostics 12.22.2. Drug Discovery & Development 12.22.3. R&D 12.23. Italy Medical Imaging Reagents Market Forecast, by Technology 12.23.1. Nanoparticles 12.23.2. Fluorescent Dyes & Probes 12.23.3. Radiopharmaceuticals 12.23.4. Fluorescent Proteins 12.23.5. Quantum Dots 12.24. Spain Medical Imaging Reagents Market Forecast, by Class 12.24.1. Contrast Reagents 12.24.2. Optical Reagents 12.24.3. Nuclear Reagents 12.25. Spain Medical Imaging Reagents Market Forecast, by Application 12.25.1. Diagnostics 12.25.2. Drug Discovery & Development 12.25.3. R&D 12.26. Spain Medical Imaging Reagents Market Forecast, by Technology 12.26.1. Nanoparticles 12.26.2. Fluorescent Dyes & Probes 12.26.3. Radiopharmaceuticals 12.26.4. Fluorescent Proteins 12.26.5. Quantum Dots 12.27. Rest of Europe Medical Imaging Reagents Market Forecast, by Class 12.27.1. Contrast Reagents 12.27.2. Optical Reagents 12.27.3. Nuclear Reagents 12.28. Rest of Europe Medical Imaging Reagents Market Forecast, by Application 12.28.1. Diagnostics 12.28.2. Drug Discovery & Development 12.28.3. R&D 12.29. Rest Of Europe Medical Imaging Reagents Market Forecast, by Technology 12.29.1. Nanoparticles 12.29.2. Fluorescent Dyes & Probes 12.29.3. Radiopharmaceuticals 12.29.4. Fluorescent Proteins 12.29.5. Quantum Dots 12.30. Europe Medical Imaging Reagents Market Attractiveness Analysis 12.30.1. By Class 12.30.2. By Application 12.30.3. By Technology 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Medical Imaging Reagents Market Analysis 13.1. Key Findings 13.2. Asia Pacific Medical Imaging Reagents Market Overview 13.3. Asia Pacific Medical Imaging Reagents Market Value Share Analysis, by Class 13.4. Asia Pacific Medical Imaging Reagents Market Forecast, by Class 13.4.1. Contrast Reagents 13.4.2. Optical Reagents 13.4.3. Nuclear Reagents 13.5. Asia Pacific Medical Imaging Reagents Market Value Share Analysis, by Application 13.6. Asia Pacific Medical Imaging Reagents Market Forecast, by Application 13.6.1. Diagnostics 13.6.2. Drug Discovery & Development 13.6.3. R&D 13.7. Asia Pacific Medical Imaging Reagents Market Value Share Analysis, by Technology 13.8. Asia Pacific Medical Imaging Reagents Market Forecast, by Technology 13.8.1. Nanoparticles 13.8.2. Fluorescent Dyes & Probes 13.8.3. Radiopharmaceuticals 13.8.4. Fluorescent Proteins 13.8.5. Quantum Dots 13.9. Asia Pacific Medical Imaging Reagents Market Value Share Analysis, by Country 13.10. Asia Pacific Medical Imaging Reagents Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Medical Imaging Reagents Market Analysis, by Country 13.12. China Medical Imaging Reagents Market Forecast, by Class 13.12.1. Contrast Reagents 13.12.2. Optical Reagents 13.12.3. Nuclear Reagents 13.13. China Medical Imaging Reagents Market Forecast, by Application 13.13.1. Diagnostics 13.13.2. Drug Discovery & Development 13.13.3. R&D 13.14. China Medical Imaging Reagents Market Forecast, by Technology 13.14.1. Nanoparticles 13.14.2. Fluorescent Dyes & Probes 13.14.3. Radiopharmaceuticals 13.14.4. Fluorescent Proteins 13.14.5. Quantum Dots 13.15. India Medical Imaging Reagents Market Forecast, by Class 13.15.1. Contrast Reagents 13.15.2. Optical Reagents 13.15.3. Nuclear Reagents 13.16. India Medical Imaging Reagents Market Forecast, by Application 13.16.1. Diagnostics 13.16.2. Drug Discovery & Development 13.16.3. R&D 13.17. India Medical Imaging Reagents Market Forecast, by Technology 13.17.1. Nanoparticles 13.17.2. Fluorescent Dyes & Probes 13.17.3. Radiopharmaceuticals 13.17.4. Fluorescent Proteins 13.17.5. Quantum Dots 13.18. Japan Medical Imaging Reagents Market Forecast, by Class 13.18.1. Contrast Reagents 13.18.2. Optical Reagents 13.18.3. Nuclear Reagents 13.19. Japan Medical Imaging Reagents Market Forecast, by Application 13.19.1. Diagnostics 13.19.2. Drug Discovery & Development 13.19.3. R&D 13.20. Japan Medical Imaging Reagents Market Forecast, by Technology 13.20.1. Nanoparticles 13.20.2. Fluorescent Dyes & Probes 13.20.3. Radiopharmaceuticals 13.20.4. Fluorescent Proteins 13.20.5. Quantum Dots 13.21. ASEAN Medical Imaging Reagents Market Forecast, by Class 13.21.1. Contrast Reagents 13.21.2. Optical Reagents 13.21.3. Nuclear Reagents 13.22. ASEAN Medical Imaging Reagents Market Forecast, by Application 13.22.1. Diagnostics 13.22.2. Drug Discovery & Development 13.22.3. R&D 13.23. ASEAN Medical Imaging Reagents Market Forecast, by Technology 13.23.1. Nanoparticles 13.23.2. Fluorescent Dyes & Probes 13.23.3. Radiopharmaceuticals 13.23.4. Fluorescent Proteins 13.23.5. Quantum Dots 13.24. Rest of Asia Pacific Medical Imaging Reagents Market Forecast, by Class 13.24.1. Contrast Reagents 13.24.2. Optical Reagents 13.24.3. Nuclear Reagents 13.25. Rest of Asia Pacific Medical Imaging Reagents Market Forecast, by Application 13.25.1. Diagnostics 13.25.2. Drug Discovery & Development 13.25.3. R&D 13.26. Rest of Asia Pacific Medical Imaging Reagents Market Forecast, by Technology 13.26.1. Nanoparticles 13.26.2. Fluorescent Dyes & Probes 13.26.3. Radiopharmaceuticals 13.26.4. Fluorescent Proteins 13.26.5. Quantum Dots 13.27. Asia Pacific Medical Imaging Reagents Market Attractiveness Analysis 13.27.1. By Class 13.27.2. By Application 13.27.3. By Technology 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Medical Imaging Reagents Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Medical Imaging Reagents Market Overview 14.3. Middle East & Africa Medical Imaging Reagents Market Value Share Analysis, by Class 14.4. Middle East & Africa Medical Imaging Reagents Market Forecast, by Class 14.4.1. Contrast Reagents 14.4.2. Optical Reagents 14.4.3. Nuclear Reagents 14.5. Middle East & Africa Medical Imaging Reagents Market Value Share Analysis, by Application 14.6. Middle East & Africa Medical Imaging Reagents Market Forecast, by Application 14.6.1. Diagnostics 14.6.2. Drug Discovery & Development 14.6.3. R&D 14.7. Middle East & Africa Medical Imaging Reagents Market Value Share Analysis, by Technology 14.8. Middle East & Africa Medical Imaging Reagents Market Forecast, by Technology 14.8.1. Nanoparticles 14.8.2. Fluorescent Dyes & Probes 14.8.3. Radiopharmaceuticals 14.8.4. Fluorescent Proteins 14.8.5. Quantum Dots 14.9. Middle East & Africa Medical Imaging Reagents Market Value Share Analysis, by Country 14.10. Middle East & Africa Medical Imaging Reagents Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Medical Imaging Reagents Market Analysis, by Country 14.12. GCC Medical Imaging Reagents Market Forecast, by Class 14.12.1. Contrast Reagents 14.12.2. Optical Reagents 14.12.3. Nuclear Reagents 14.13. GCC Medical Imaging Reagents Market Forecast, by Application 14.13.1. Diagnostics 14.13.2. Drug Discovery & Development 14.13.3. R&D 14.14. GCC Medical Imaging Reagents Market Forecast, by Technology 14.14.1. Nanoparticles 14.14.2. Fluorescent Dyes & Probes 14.14.3. Radiopharmaceuticals 14.14.4. Fluorescent Proteins 14.14.5. Quantum Dots 14.15. South Africa Medical Imaging Reagents Market Forecast, by Class 14.15.1. Contrast Reagents 14.15.2. Optical Reagents 14.15.3. Nuclear Reagents 14.16. South Africa Medical Imaging Reagents Market Forecast, by Application 14.16.1. Diagnostics 14.16.2. Drug Discovery & Development 14.16.3. R&D 14.17. South Africa Medical Imaging Reagents Market Forecast, by Technology 14.17.1. Nanoparticles 14.17.2. Fluorescent Dyes & Probes 14.17.3. Radiopharmaceuticals 14.17.4. Fluorescent Proteins 14.17.5. Quantum Dots 14.18. Rest of Middle East & Africa Medical Imaging Reagents Market Forecast, by Class 14.18.1. Contrast Reagents 14.18.2. Optical Reagents 14.18.3. Nuclear Reagents 14.19. Rest of Middle East & Africa Medical Imaging Reagents Market Forecast, by Application 14.19.1. Diagnostics 14.19.2. Drug Discovery & Development 14.19.3. R&D 14.20. Rest of Middle East & Africa Medical Imaging Reagents Market Forecast, by Technology 14.20.1. Nanoparticles 14.20.2. Fluorescent Dyes & Probes 14.20.3. Radiopharmaceuticals 14.20.4. Fluorescent Proteins 14.20.5. Quantum Dots 14.21. Middle East & Africa Medical Imaging Reagents Market Attractiveness Analysis 14.21.1. By Class 14.21.2. By Application 14.21.3. By Technology 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Medical Imaging Reagents Market Analysis 15.1. Key Findings 15.2. South America Medical Imaging Reagents Market Overview 15.3. South America Medical Imaging Reagents Market Value Share Analysis, by Class 15.4. South America Medical Imaging Reagents Market Forecast, by Class 15.4.1. Contrast Reagents 15.4.2. Optical Reagents 15.4.3. Nuclear Reagents 15.5. South America Medical Imaging Reagents Market Value Share Analysis, by Application 15.6. South America Medical Imaging Reagents Market Forecast, by Application 15.6.1. Diagnostics 15.6.2. Drug Discovery & Development 15.6.3. R&D 15.7. South America Medical Imaging Reagents Market Value Share Analysis, by Technology 15.8. South America Medical Imaging Reagents Market Forecast, by Technology 15.8.1. Nanoparticles 15.8.2. Fluorescent Dyes & Probes 15.8.3. Radiopharmaceuticals 15.8.4. Fluorescent Proteins 15.8.5. Quantum Dots 15.9. South America Medical Imaging Reagents Market Value Share Analysis, by Country 15.10. South America Medical Imaging Reagents Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Medical Imaging Reagents Market Analysis, by Country 15.12. Brazil Medical Imaging Reagents Market Forecast, by Class 15.12.1. Contrast Reagents 15.12.2. Optical Reagents 15.12.3. Nuclear Reagents 15.13. Brazil Medical Imaging Reagents Market Forecast, by Application 15.13.1. Diagnostics 15.13.2. Drug Discovery & Development 15.13.3. R&D 15.14. Brazil Medical Imaging Reagents Market Forecast, by Technology 15.14.1. Nanoparticles 15.14.2. Fluorescent Dyes & Probes 15.14.3. Radiopharmaceuticals 15.14.4. Fluorescent Proteins 15.14.5. Quantum Dots 15.15. Mexico Medical Imaging Reagents Market Forecast, by Class 15.15.1. Contrast Reagents 15.15.2. Optical Reagents 15.15.3. Nuclear Reagents 15.16. Mexico Medical Imaging Reagents Market Forecast, by Application 15.16.1. Diagnostics 15.16.2. Drug Discovery & Development 15.16.3. R&D 15.17. Mexico Medical Imaging Reagents Market Forecast, by Technology 15.17.1. Nanoparticles 15.17.2. Fluorescent Dyes & Probes 15.17.3. Radiopharmaceuticals 15.17.4. Fluorescent Proteins 15.17.5. Quantum Dots 15.18. Rest of South America Medical Imaging Reagents Market Forecast, by Class 15.18.1. Contrast Reagents 15.18.2. Optical Reagents 15.18.3. Nuclear Reagents 15.19. Rest of South America Medical Imaging Reagents Market Forecast, by Application 15.19.1. Diagnostics 15.19.2. Drug Discovery & Development 15.19.3. R&D 15.20. Rest of South America Medical Imaging Reagents Market Forecast, by Technology 15.20.1. Nanoparticles 15.20.2. Fluorescent Dyes & Probes 15.20.3. Radiopharmaceuticals 15.20.4. Fluorescent Proteins 15.20.5. Quantum Dots 15.21. South America Medical Imaging Reagents Market Attractiveness Analysis 15.21.1. By Class 15.21.2. By Application 15.21.3. By Technology 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New product Launches and product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Bayer Healthcare AG 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Developing Footprint 16.3.2. Becton Dickinson & Company 16.3.3. Bracco Imaging SpA 16.3.4. Cardinal Health, Inc. 16.3.5. GE Healthcare 16.3.6. Lantheus Medical Imaging, Inc. 16.3.7. Mallinckrodt Pharmaceuticals 16.3.8. Thermo Fisher Scientific, Inc. 16.3.9. Promega Corporation 16.3.10. Danaher Corporation 16.3.11. Siemens Healthcare 16.3.12. Merck & Co., Inc. 16.3.13. Shimadzu Corporation 16.3.14. Koninklijke Philips N.V. 16.3.15. Covalon Technologies Ltd., 16.3.16. Guerbet Group 16.3.17. Isologic Innovative Radiopharmaceuticals 16.3.18. Piramal Imaging 16.3.19. SHINE Medical Technologies 17. Primary Key Insights
  • INQUIRE BEFORE BUYING